Indegene Ltd was incorporated as `Indegene Lifesystems Private Limited` at Ahmedabad, Gujarat, as a Private Limited Company, dated
October 16, 1998 at Ahmedabad. Subsequently, name of the Company was changed to `Indegene Private Limited` and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. Thereafter, Company converted to a Public Company with change in name to `Indegene Limited` and a fresh certificate of incorporation was issued to Company by RoC, on November 17, 2022.
The Company is a "digital-first" commercialization company focused exclusively on the global life sciences industry. Their solutions
enable biopharmaceutical, emerging biotech and medical devices companies develop products, launch them in the market, and
drive sales through their life cycle in a more effective, efficient and modern manner. Their portfolio of solutions cover all aspects of
commercial, medical, regulatory and R&D operations of life sciences companies.
Their Enterprise Commercial Solutions (ECS) involve assisting life sciences companies with their digital marketing operations. Omnichannel Activation solutions help life sciences companies leverage a "digital first" approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to HCPs across multiple channels. Under Enterprise Medical Solutions, the Company establish centers of excellence (CoEs) to consolidate large scale regulatory and medical operations for their clients.
Apart from these, the Company offer Enterprise Clinical Solutions and consultancy services, which help drive efficiencies in the drug discovery and clinical trial operations of life sciences companies. It bring in their expertise in data management and analytics
in helping biopharmaceutical companies seamlessly handle and analyze multiple sources of data during clinical trials and build a case for regulatory approvals.
In 2016, the Company acquired Encima Group, Inc. in the United States, a company which provided marketing analytics and campaign execution solutions to several large life sciences companies.
In 2019, it acquired a minority stake in DT Associates Research and Consulting Services Limited, a digital transformation and client experience consulting firm in UK, to expand their strategic consulting capabilities. In December 2020, it acquired a majority stake in DT Associates Limited.
On 8 December, 2021 the Company has demerged its commercial software business pursuant to a Scheme of Arrangement for transfer of the Demerged Business to OT Services India Private Limited (Resulting Company), approved by the National Company Law Tribunal, Bengaluru Bench with Appointed Date, i.e., October 1, 2020, which became effective on December 30, 2021.
The Company acquired Cult Health, a full-service healthcare marketing agency for several life sciences brands, through its subsidiary, ILSL Holdings, Inc. on October 12, 2022.
The Company is planning to raise capital from Public by raising Rs 950 crores through fresh issue and 36,291,497 Equity Shares through Offer For Sale.
Indegene share price as on 08 Sep 2024 is Rs. 664.7. Over the past 6 months, the Indegene share price has increased by 0% and in the last one year, it has increased by 16.43%. The 52-week low for Indegene share price was Rs. 470.1 and 52-week high was Rs. 689.95.